Abstract:Rapid developments in Regenerative Medicine and Tissue Engineering has witnessed an increasing drive toward clinical translation of breakthrough technologies. However, the progression of promising preclinical data to achieve successful clinical market authorisation remains a bottleneck. One hurdle for progress to the clinic is the transition from small animal research to advanced preclinical studies in large animals to test safety and efficacy of products. Notwithstanding this, to draw meaningful and reliable conclusions from animal experiments it is critical that the species and disease model of choice is relevant to answer the research question as well as the clinical problem. Selecting the most appropriate animal model requires in-depth knowledge of specific species and breeds to ascertain the adequacy of the model and outcome measures that closely mirror the clinical situation. Traditional reductionist approaches in animal experiments, which often do not sufficiently reflect the studied disease, are still the norm and can result in a disconnect in outcomes observed between animal studies and clinical trials. To address these concerns a reconsideration in approach will be required. This should include a stepwise approach using in vitro and ex vivo experiments as well as in silico modeling to minimize the need for in vivo studies for screening and early development studies, followed by large animal models which more closely resemble human disease. Naturally occurring, or spontaneous diseases in large animals remain a largely untapped resource, and given the similarities in pathophysiology to humans they not only allow for studying new treatment strategies but also disease etiology and prevention. Naturally occurring disease models, particularly for longer lived large animal species, allow for studying disorders at an age when the disease is most prevalent. As these diseases are usually also a concern in the chosen veterinary species they would be beneficiaries of newly developed therapies. Improved awareness of the progress in animal models is mutually beneficial for animals, researchers, human and veterinary patients. In this overview we describe advantages and disadvantages of various animal models including domesticated and companion animals used in regenerative medicine and tissue engineering to provide an informed choice of disease-relevant animal models.

A Concise Review of Common Animal Models for the Study of Limb Regeneration.

Mechanisms and Translational Applications of Regeneration in Limbs: from Renewable Animals to Humans

Small Mammalian Animal Models of Heart Disease.

Perspectives on Animal Models Utilized for the Research and Development of Regenerative Therapies for Articular Cartilage

Amphibians As Research Models for Regenerative Medicine

Using zebrafish as the model organism to understand organ regeneration

Animal Models of Osteochondral Defect for Testing Biomaterials

Animal experimental models of ischemic wounds – A review of literature

Evaluation of Spinal Cord Injury Animal Models

Exploring the Use of Animal Models in Craniofacial Regenerative Medicine: A Narrative Review

Subtractive Screen of Potential Limb Regeneration Related Genes from Pachytriton Brevipes

Large Mammalian Animal Models of Heart Disease

Molecular mechanisms of spinal cord injury repair across vertebrates: A comparative review

Large Animal Models in Regenerative Medicine and Tissue Engineering: To Do or Not to Do

Effects of life history strategies and habitats on limb regeneration in plethodontid salamanders

Review. Limb regeneration in lizards under natural and experimental conditions with considerations on the induction of appendages regeneration in amniotes

Role of animal models in biomedical research: a review

A functional model for whole limb transplantation in the rat

Animal Models for the Atherosclerosis Research: a Review

Lizard tail regeneration as an instructive model of enhanced healing capabilities in an adult amniote

Selection of animal models for pre-clinical strategies in evaluating the fracture healing, bone graft substitutes and bone tissue regeneration and engineering